GMED

Globus Medical

Price

$76.43

return (12m)

26.50%

p/e

15.83

p/bv

2.19

DIVIDEND YIELD

0.00%

GMED price

Globus Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GMED

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.04%

3 months

-1.99%

1 year

26.50%

2 years

9.09%

5 years

1.20%

10 years

227.89%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals GMED

Valuation

P/E

15.83

Sector 7.51

Industry 7.51

P/BV

2.19

Sector 1.74

Industry 1.74

P/Revenue (PSR)

3.32

Sector 1.68

Industry 1.68

EV/EBITDA

Sector -852.16

Industry -852.16

EV/EBIT

Sector -3,345.23

Industry -3,345.23

P/EBITDA

21.68

Sector -14.17

Industry -14.17

P/EBIT

79.72

Sector -12.30

Industry -12.30

P/Total Assets

1.90

Sector 0.82

Industry 0.82

P/Net Current Assets

6.98

Sector -1.92

Industry -1.92

P/Working Capital

6.01

Sector -0.44

Industry -0.44

EPS

4.77

Sector 0.70

Industry 0.70

BVPS

34.51

Sector 9.80

Industry 9.80

Efficiency

Gross Margin

68.55%

Sector 35.93%

Industry 35.93%

EBITDA Margin

Sector -179.35%

Industry -179.35%

EBIT Margin

-17.65%

Sector 1.29%

Industry 1.29%

Operating Margin

20.75%

Sector 4.50%

Industry 4.50%

Net Profit Margins

20.98%

Sector 2.55%

Industry 2.55%

Asset Turnover

0.14

Sector 0.11

Industry 0.11

Profitability

ROE

13.83%

Sector 2.61%

Industry 2.61%

ROA

12.02%

Sector -0.61%

Industry -0.61%

ROIC

Sector -120.63%

Industry -120.63%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

0.00%

Sector 9.83%

Industry 9.83%

Debt

Current Ratio

4.62

Sector 1.47

Industry 1.47

Net Debt / EBITDA

Sector -20.55

Industry -20.55

Net Debt / EBIT

Sector -170,977,300.09

Industry -170,977,300.09

Net Debt / Equity

Sector -0.78

Industry -0.78

Gross Debt / Equity

Sector -0.51

Industry -0.51

Equity/Assets

0.87

Sector 0.43

Industry 0.43

Liabilities/Assets

0.13

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

26.83%

Sector -

Industry -

5Y Earnings CAGR

34.62%

Sector -

Industry -

Fundamentals GMED

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Globus Medical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$76.43

Fair Value

$60.86

Upside

-20.37%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

GMED - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Globus Medical

Globus Medical

Average Investor10 user rating

4.0 (1 people)

United States

23 years

Founded: 2003

2012

Time since IPO - 14 years

6.000

Employees

Globus Medical (United States) is listed on the Nasdaq and has a market capitalization of $10.44 billion, with shareholders equity totaling $4.77 billion.

The company employs approximately 6.000 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Globus Medical reported $3.14 billion in revenue, generating net income of $659.73 million.

Key financial metrics include a P/E ratio of 15.83, a price-to-book (P/B) ratio of 2.19, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GMED.

Market cap

$10.44 billion

Net worth

$4.77 billion

$4,768,603,000.00

Assets

$5.49 billion

$5,488,258,000.00

Total Shares Outstanding

138.19 million

138,191,000

Average Daily Trading Volume

$1.75 million

$1,750,128.00

Sector

Others

Industry

Others

GMED

GMED revenue and profits

Financial Results GMED

DRAG THE FRAME TO SEE MORE DATA

GMED cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$375.98 4,34% (12M)

P/E

23.51

2.46%

ROE

13.51%

P/BV

3.18

SHEL - Shell PLC ADR

$96.85 35,53% (12M)

P/E

10.30

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.61 --57,31% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$317.25 2,91% (12M)

P/E

22.61

0.78%

ROE

81.03%

P/BV

18.32

ALIZY - Allianz SE ADR

$46.66 --19,63% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$84.21 51,59% (12M)

P/E

6.86

4.78%

ROE

21.42%

P/BV

1.47

NSRGY - Nestle SA ADR

$90.62 1,05% (12M)

P/E

10.81

4.45%

ROE

58.05%

P/BV

6.27

ELV - Elevance Health Inc

$404.31 13,79% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96